See more : AB Science S.A. (0Q77.L) Income Statement Analysis – Financial Results
Complete financial analysis of DaVita Inc. (DVA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of DaVita Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- Uni-President Enterprises Corp. (1216.TW) Income Statement Analysis – Financial Results
- Alpha MOS S.A. (ALM.PA) Income Statement Analysis – Financial Results
- Leclanché SA (LECN.SW) Income Statement Analysis – Financial Results
- Poxel S.A. (POXEL.PA) Income Statement Analysis – Financial Results
- GURU Organic Energy Corp. (GURU.TO) Income Statement Analysis – Financial Results
DaVita Inc. (DVA)
About DaVita Inc.
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 12.14B | 11.61B | 11.62B | 11.55B | 11.39B | 11.40B | 10.88B | 14.75B | 13.78B | 12.80B | 11.76B | 8.19B | 6.79B | 6.45B | 6.11B | 5.66B | 5.26B | 4.88B | 2.97B | 2.30B | 2.05B | 1.85B | 1.65B | 1.49B | 1.45B | 1.20B | 438.20M | 272.90M | 89.70M | 99.00M |
| Cost of Revenue | 8.32B | 8.21B | 7.97B | 7.99B | 7.91B | 8.20B | 7.64B | 10.65B | 9.82B | 9.12B | 8.20B | 5.58B | 4.68B | 4.47B | 4.25B | 3.92B | 3.59B | 3.39B | 2.04B | 1.56B | 1.36B | 1.22B | 1.10B | 1.03B | 993.24M | 772.70M | 292.50M | 184.00M | 57.40M | 65.60M |
| Gross Profit | 3.82B | 3.40B | 3.65B | 3.56B | 3.47B | 3.21B | 3.24B | 4.10B | 3.96B | 3.68B | 3.57B | 2.61B | 2.11B | 1.97B | 1.86B | 1.74B | 1.67B | 1.49B | 938.68M | 743.53M | 685.86M | 636.95M | 550.10M | 454.15M | 452.11M | 432.20M | 145.70M | 88.90M | 32.30M | 33.40M |
| Gross Profit Ratio | 31.47% | 29.29% | 31.38% | 30.84% | 30.50% | 28.14% | 29.76% | 27.79% | 28.71% | 28.73% | 30.31% | 31.85% | 31.08% | 30.60% | 30.45% | 30.74% | 31.80% | 30.54% | 31.56% | 32.35% | 33.52% | 34.34% | 33.32% | 30.56% | 31.28% | 35.87% | 33.25% | 32.58% | 36.01% | 33.74% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.47B | 1.36B | 1.20B | 1.25B | 1.10B | 1.14B | 1.06B | 1.59B | 1.45B | 1.26B | 1.18B | 894.58M | 691.24M | 579.00M | 531.53M | 654.47M | 627.92M | 579.72M | 334.38M | 233.04M | 195.33M | 181.33M | 126.90M | 163.27M | 263.81M | 120.20M | 38.70M | 24.80M | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.47B | 1.36B | 1.20B | 1.25B | 1.10B | 1.14B | 1.06B | 1.59B | 1.45B | 1.26B | 1.18B | 894.58M | 691.24M | 579.00M | 531.53M | 654.47M | 627.92M | 579.72M | 334.38M | 233.04M | 195.33M | 181.33M | 126.90M | 163.27M | 263.81M | 120.20M | 38.70M | 24.80M | 9.40M | 11.50M |
| Other Expenses | 743.66M | 732.60M | 680.62M | 630.44M | 615.15M | 583.74M | 17.67M | 8.73M | 8.89M | 2.37M | 4.79M | 3.74M | 455.42M | 396.63M | 388.33M | 263.45M | 183.68M | 171.16M | 138.93M | 100.36M | 112.00M | 64.29M | 105.21M | 111.61M | 112.48M | 92.00M | 27.10M | 15.40M | 4.40M | 0.00 |
| Operating Expenses | 2.22B | 2.09B | 1.88B | 1.88B | 1.72B | 1.72B | 1.62B | 2.32B | 2.59B | 1.88B | 2.11B | 1.33B | 956.43M | 975.63M | 919.86M | 917.92M | 811.60M | 750.88M | 473.30M | 333.40M | 307.33M | 245.62M | 232.11M | 274.88M | 376.29M | 212.20M | 65.80M | 40.20M | 13.80M | 16.20M |
| Cost & Expenses | 10.54B | 10.30B | 9.85B | 9.87B | 9.63B | 9.91B | 9.26B | 12.97B | 12.42B | 11.00B | 10.31B | 6.91B | 5.64B | 5.45B | 5.17B | 4.84B | 4.40B | 4.14B | 2.51B | 1.89B | 1.67B | 1.46B | 1.33B | 1.31B | 1.37B | 984.90M | 358.30M | 224.20M | 71.20M | 81.80M |
| Interest Income | 0.00 | 368.75M | 279.75M | 297.03M | 435.23M | 0.00 | 0.00 | 0.00 | 0.00 | 17.41M | 0.00 | 288.53M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 398.55M | 357.02M | 285.25M | 304.11M | 443.82M | 487.44M | 430.63M | 414.38M | 405.94M | 410.29M | 429.94M | 0.00 | 241.09M | 255.99M | 185.76M | 199.89M | 156.95M | 489.02M | 107.74M | 44.07M | 113.71M | 98.33M | 71.43M | 149.58M | 399.35M | 256.00M | 15.40M | 14.40M | 4.10M | 0.00 |
| Depreciation & Amortization | 745.44M | 732.60M | 680.62M | 630.44M | 615.15M | 591.04M | 559.91M | 509.50M | 638.02M | 590.94M | 528.12M | 343.91M | 267.32M | 234.38M | 228.99M | 216.92M | 193.47M | 173.30M | 119.72M | 86.67M | 74.69M | 64.67M | 105.21M | 111.61M | 112.48M | 92.00M | 27.10M | 15.40M | 4.40M | 4.70M |
| EBITDA | 2.35B | 2.05B | 2.45B | 2.31B | 2.37B | 2.08B | 2.38B | 2.55B | 1.77B | 2.43B | 2.10B | 1.63B | 1.43B | 1.23B | 1.16B | 1.03B | 1.06B | 912.73M | 465.37M | 467.79M | 434.62M | 448.49M | 416.07M | 290.88M | 188.30M | 303.40M | 165.20M | 105.70M | 33.20M | 21.90M |
| EBITDA Ratio | 19.33% | 17.71% | 21.38% | 20.42% | 21.19% | 18.30% | 22.12% | 17.06% | 14.37% | 18.06% | 17.23% | 19.96% | 20.94% | 19.10% | 19.14% | 18.13% | 18.58% | 23.33% | 19.50% | 21.43% | 23.29% | 24.25% | 25.36% | 20.36% | 22.83% | 31.98% | 23.87% | 22.79% | 24.75% | 22.12% |
| Operating Income | 1.60B | 1.34B | 1.80B | 1.69B | 1.64B | 1.53B | 1.81B | 1.89B | 1.17B | 1.82B | 1.55B | 1.30B | 1.13B | 997.03M | 940.27M | 821.77M | 862.21M | 739.43M | 465.37M | 410.12M | 378.54M | 391.33M | 317.99M | 179.27M | 75.82M | 220.00M | 79.90M | 48.70M | 18.50M | 17.20M |
| Operating Income Ratio | 13.20% | 11.53% | 15.47% | 14.67% | 14.43% | 13.38% | 16.67% | 12.85% | 8.49% | 14.19% | 13.18% | 15.84% | 16.65% | 15.46% | 15.39% | 14.52% | 16.38% | 15.15% | 15.65% | 17.84% | 18.50% | 21.10% | 19.26% | 12.06% | 5.25% | 18.26% | 18.23% | 17.85% | 20.62% | 17.37% |
| Total Other Income/Expenses | -425.69M | -372.78M | -278.88M | -376.37M | -447.88M | -477.35M | -412.97M | -406.61M | -413.63M | -505.47M | -425.16M | -295.78M | -238.11M | -252.57M | -182.05M | -164.97M | -234.69M | -263.67M | -134.27M | -19.24M | -71.67M | -67.64M | -68.29M | -134.34M | -257.65M | -164.40M | 1.30M | 8.70M | -3.60M | -8.80M |
| Income Before Tax | 1.18B | 966.28M | 1.52B | 1.32B | 1.20B | 1.05B | 1.40B | 1.49B | 723.14M | 1.31B | 1.12B | 1.00B | 892.67M | 744.46M | 758.22M | 609.46M | 627.52M | 475.76M | 331.10M | 361.88M | 288.27M | 316.19M | 240.94M | 44.94M | -181.83M | 56.90M | 62.10M | 40.10M | 11.10M | 8.40M |
| Income Before Tax Ratio | 9.70% | 8.32% | 13.07% | 11.41% | 10.50% | 9.19% | 12.87% | 10.10% | 5.25% | 10.24% | 9.56% | 12.23% | 13.14% | 11.55% | 12.41% | 10.77% | 11.92% | 9.75% | 11.13% | 15.74% | 14.09% | 17.05% | 14.60% | 3.02% | -12.58% | 4.72% | 14.17% | 14.69% | 12.37% | 8.48% |
| Income Tax Expense | 220.12M | 198.09M | 306.73M | 313.93M | 279.63M | 258.40M | 323.86M | 455.81M | 295.73M | 446.34M | 381.01M | 359.85M | 315.74M | 260.24M | 278.47M | 235.30M | 245.74M | 186.43M | 123.68M | 139.63M | 112.48M | 129.50M | 104.60M | 27.96M | -34.57M | 41.60M | 25.10M | 16.40M | 4.60M | 3.50M |
| Net Income | 691.54M | 768.19M | 978.45M | 773.64M | 810.98M | 790.08M | 663.62M | 879.87M | 269.73M | 723.11M | 633.45M | 536.02M | 478.00M | 405.68M | 422.68M | 374.16M | 381.78M | 289.69M | 228.64M | 222.25M | 175.79M | 157.33M | 137.32M | 13.49M | -147.26M | -4.30M | 37.00M | 16.00M | 9.10M | 4.90M |
| Net Income Ratio | 5.70% | 6.62% | 8.42% | 6.70% | 7.12% | 6.93% | 6.10% | 5.97% | 1.96% | 5.65% | 5.38% | 6.55% | 7.04% | 6.29% | 6.92% | 6.61% | 7.25% | 5.94% | 7.69% | 9.67% | 8.59% | 8.48% | 8.32% | 0.91% | -10.19% | -0.36% | 8.44% | 5.86% | 10.14% | 4.95% |
| EPS | 7.62 | 8.26 | 9.30 | 6.54 | 5.29 | 4.63 | 3.52 | 4.36 | 1.27 | 3.41 | 3.02 | 2.79 | 2.52 | 2.00 | 2.04 | 1.78 | 1.80 | 1.40 | 1.13 | 1.13 | 0.93 | 0.73 | 0.55 | 0.06 | -0.60 | -0.02 | 0.24 | 0.14 | 0.08 | 0.09 |
| EPS Diluted | 7.42 | 8.02 | 8.90 | 6.39 | 5.27 | 4.58 | 3.47 | 4.29 | 1.25 | 3.33 | 2.95 | 2.74 | 2.48 | 1.97 | 2.03 | 1.77 | 1.78 | 1.37 | 1.10 | 1.08 | 0.77 | 0.58 | 0.49 | 0.05 | -0.60 | -0.02 | 0.24 | 0.13 | 0.08 | 0.08 |
| Weighted Avg Shares Out | 90.79M | 92.99M | 105.23M | 119.80M | 153.18M | 170.79M | 188.63M | 201.64M | 211.87M | 212.30M | 209.94M | 192.04M | 189.32M | 203.01M | 207.21M | 210.30M | 211.79M | 207.04M | 201.52M | 197.45M | 188.69M | 215.49M | 251.30M | 244.74M | 243.46M | 240.43M | 155.05M | 114.73M | 111.48M | 54.42M |
| Weighted Avg Shares Out (Dil) | 93.18M | 95.83M | 109.95M | 122.62M | 153.81M | 172.36M | 191.35M | 204.90M | 216.25M | 216.93M | 214.76M | 195.94M | 193.06M | 206.12M | 208.34M | 211.88M | 214.84M | 211.59M | 208.14M | 205.72M | 227.52M | 271.44M | 278.82M | 249.47M | 243.46M | 245.10M | 155.05M | 119.94M | 111.48M | 61.22M |
The Best Warren Buffett Stocks to Buy With $1,000 Right Now
Warren Buffett, the longtime head of Berkshire Hathaway (BRK.A 0.99%) (BRK.B 0.95%), has delivered an impressive nearly 20% annualized return for shareholders since 1965, doubling the S&P 500's benchmark return. These exceptional results stem from Buffett and his late partner...
DaVita: Better Results Than Fresenius, But A 'Hold' Due To Valuation
Despite operational success and growth potential, I rate DaVita Inc. a “Hold” due to its high debt, lack of dividend, and current overvaluation. DaVita excels in dialysis services but faces significant risks from debt servicing costs, macroeconomic factors, and potential...
DaVita's "Move It With Purpose" Sets Record Participation in Support of Global Health
More than 8,300 people joined the annual event to raise funds for Bridge of Life DENVER , Nov. 12, 2024 /PRNewswire/ -- DaVita, a leading provider of kidney care services, today announced the success of its third annual Move It With...
DaVita Inc. to Participate in UBS Global Healthcare Conference 2024
DENVER , Nov. 8, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will participate in a fireside chat with investors at UBS...
Why DaVita Stock Withered on Wednesday
The company's profitability is going in the wrong direction for many investors.
Two Warren Buffett Stocks Get Pounded, With Apple Earnings Due
This week marks a fire hose of earnings from several top Warren Buffett stock holdings. "Extraordinary business" Apple is on deck Thursday.
DaVita Stock Declines After Q3 Earnings Miss Estimates, Margins Up
DVA's robust Dialysis patient service revenues drives its third-quarter performance.
DaVita Inc. (DVA) Q3 2024 Earnings Call Transcript
DaVita Inc. (NYSE:DVA ) Q3 2024 Earnings Conference Call October 29, 2024 5:00 PM ET Company Participants Nic Eliason - Group Vice President, Investor Relations Javier Rodriguez - Chief Executive Officer Joel Ackerman - Chief Financial Officer Conference Call Participants...
DaVita HealthCare (DVA) Q3 Earnings Miss Estimates
DaVita HealthCare (DVA) came out with quarterly earnings of $2.59 per share, missing the Zacks Consensus Estimate of $2.76 per share. This compares to earnings of $2.85 per share a year ago.
DaVita misses third-quarter profit estimates on higher costs
DaVita reported third-quarter profit that missed Wall Street estimates on Tuesday, hurt by high patient care costs.
Source: https://incomestatements.info
Category: Stock Reports